看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。& z' p7 ?" j( b# q2 P, t- E
g" U5 V: ^9 C/ R" Y6 {) u
" f3 w+ D) m, L- V8 RCurrently available feasibility data for possible combination strategies.
+ D' U$ S; W# f" f Y————————————————————————————————+ L8 Z8 Q4 H: z" M5 c
Combination Feasibility according to preliminary data $ q9 [0 v# o# V) c/ f! C
——————————————————————————————————
5 M; ^( h+ y0 d4 k5 cBevacizumab + sorafenib Yes, reduced dose 9 ~) x- a) R1 _. l2 C' T
Bevacizumab + sunitinib† No
4 C9 \% Z) s9 R( k' `) V- RBevacizumab + temsirolimus Yes
$ j: ^5 _7 I% h j. q0 fBevacizumab + everolimus Yes
* E8 Y5 E: |9 I- a' d8 G7 ^Sorafenib + sunitinib ?
) p) z: W: m3 X/ J! cSorafenib + temsirolimus Yes, reduced dose
# P% F+ J) G: A! O, y7 kSorafenib + everolimus Yes, reduced dose / w M$ O- ~$ Y. P2 A& e. v! D
Sunitinib + temsirolimus† No
) I; h7 [4 l+ {* Y; KSunitinib + everolimus ?
; p( U1 a. `: f& C$ E' \/ sTemsirolimus + everolimus ? 4 S) D9 l$ g( Y2 K: d. B* @/ @
————————————————————( l! C; E$ `$ k! _
†Led to US FDA warning.
: S, j) C) K' I?: As yet unattempted combination.
3 N4 {0 _/ w- a0 M |